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Abstract
Background: There is a strong association between stillbirth and fetal growth restriction. Early detection and
management of IUGR can lead to reduce related morbidity and mortality. In this paper we have reviewed
effectiveness of fetal movement monitoring and Doppler velocimetry for the detection and surveillance of high risk
pregnancies and the effect of this on prevention of stillbirths. We have also reviewed effect of maternal body mass
index (BMI) screening, symphysial-fundal height measurement and targeted ultrasound in detection and triage of
IUGR in the community.
Methods: We systematically reviewed all published literature to identify studies related to our interventions. We
searched PubMed, Cochrane Library, and all World Health Organization Regional Databases and included
publications in any language. Quality of available evidence was assessed using GRADE criteria. Recommendations
were made for the Lives Saved Tool (LiST) based on rules developed by the Child Health Epidemiology Group.
Given the paucity of evidence related to the effect of detection and management of IUGR on stillbirths, we
undertook Delphi based evaluation from experts in the field.
Results: There was insufficient evidence to recommend against or in favor of routine use of fetal movement
monitoring for fetal well being. (1) Detection and triage of IUGR with the help of (1a) maternal BMI screening, (1b)
symphysial-fundal height measurement and (1c) targeted ultrasound can be an effective method of reducing IUGR
related perinatal morbidity and mortality. Pooled results from sixteen studies shows that Doppler velocimetry of
umbilical and fetal arteries in ‘high risk’ pregnancies, coupled with the appropriate intervention, can reduce
perinatal mortality by 29 % [RR 0.71, 95 % CI 0.52-0.98]. Pooled results for impact on stillbirth showed a reduction
of 35 % [RR 0.65, 95 % CI 0.41-1.04]; however, the results did not reach the conventional limits of statistical
significance. This intervention could be potentially recommended for high income settings or middle income
countries with improving rates and standards of facility based care. Based on the Delphi, a combination of
screening with maternal BMI, Symphysis fundal height and targeted ultrasound followed by the appropriate
management could potentially reduce antepartum and intrapartum stillbirth by 20% respectively. This estimate is
presently being recommended for inclusion in the LiST.
Conclusion: There is insufficient evidence to recommend in favor or against fetal movement counting for routine
use for testing fetal well being. Doppler velocimetry of umbilical and fetal arteries and appropriate intervention is
associated with 29 % (95 % CI 2% to 48 %) reduction in perinatal mortality. Expert opinion suggests that detection
and management of IUGR with the help of maternal BMI, symphysial-fundal height measurement and targeted
ultrasound could be effective in reducing IUGR related stillbirths by 20%.
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Background
Intrauterine growth restriction (IUGR) represents patho-
logical inhibition of fetal growth and failure of the fetus
to attain its growth potential [1]. There is a strong asso-
ciation between stillbirth and fetal growth restriction [2].
The etiology and risk factors for stillbirth and IUGR
largely overlap [3,4]. Both the conditions are the result of
complex pathology resulting from a recognizable interac-
tion among maternal conditions, placental dysfunction
and hormonal regulation [2,4]. For example, maternal
smoking, low educational level, advanced maternal age,
nulliparity, and black race are associated with increased
risk of fetal growth restriction and stillbirth [2,4,5]. The
same is the case for maternal medical conditions like
gestational hypertensive disorders, pre and gestational
diabetes, systemic lupus erythematosus, chronic renal
disease, and thyroid disorders [2,3,6]. Further evidence of
strong association between IUGR and stillbirth comes
from the fact that prior delivery of a growth restricted
infant is among the strongest risk factors for stillbirth,
comparable to the history of prior stillbirth [3].
IUGR has been used as a marker to assess complica-
tions of pregnancy [7]. There is however, no standard
definition of IUGR. It has been defined as a birth weight
< 2 standard deviations below the median for gestational
age, whereas others use a threshold of 3rd or 5th per-
centile of weight for age for the given population [7,8].
The term small for gestational age (SGA), usually
defined as having a birth weight below the 10th percen-
tile of an accepted reference standard, is often used as a
proxy measure for IUGR [8]. These two terms are how-
ever not synonymous as some SGA infants may merely
represent the lower tail of the ‘normal’ fetal growth dis-
tribution, while others who have been affected in utero
by an inadequate nutritional milieu or other growth-
inhibiting influences may nevertheless have a birth
weight that is ‘appropriate’ for gestational age (AGA)
[8]. Even though the terms SGA and IUGR are not
synonymous, there is correlation between the two and
the higher the SGA rate, the greater the likelihood that
SGA is a result of IUGR [9].
According to an estimate, approximately 30 million
newborns per year are affected with intrauterine growth
restriction in developing countries [4]. This rate is six
times higher than that in developed countries. The high-
est burden of prevalence of SGA/IUGR babies lies in
Asia (75%), mainly South East Asia, followed by Africa
(20%) and Latin America (5%) [4].
In order to prevent complications associated with
intrauterine growth restriction, it is important to first
detect the condition and once detected, institute appro-
priate surveillance to asses fetal well being coupled with
suitable intervention in case of fetal distress (for example
early delivery) [1,10]. The primary purpose of this paper
is to assess screening and surveillance interventions that
can help prevent stillbirths associated with IUGR. In this
paper we review the methods used to detect IUGR fol-
lowed by the methods used for surveillance of such high
risk pregnancies. This paper is part of series of papers to
estimate effectiveness of an intervention for input to
Lives Saved Tool (LiST) model [11]. An intervention is
currently included in the LiST if there is evidence that it
reduces maternal mortality, infant/child mortality
(<5 years) and/or stillbirths. The process of generating
recommendations for an intervention involve qualitative
evaluation of available evidence according to GRADE cri-
teria [12] and quantitative evaluation according to Child
Health Epidemiology Reference Group (CHERG) rules
[11]. For more details of the review methods, the adapted
GRADE approach or the LiST model see the methods
section and the CHERG method paper [11]. For the pur-
pose of simplicity, we will divide this review into parts.
1. The detection of IUGR.
2. Surveillance of high risk pregnancies.
Methods
Search strategy
We systematically reviewed all published literature to
identify studies evaluating role of (1) fetal movement
monitoring and (2) Doppler ultrasound in high risk preg-
nancies in reducing perinatal mortality and stillbirths.
We searched PubMed, Cochrane Library, and all World
Health Organization Regional Databases and included
publications in any language. The search strategies used
for the above mentioned screening strategies are given in
Additional file 1. Last date of search was 3rd March 2010.
We scanned the titles and abstracts of the studies identi-
fied to exclude those that were obviously irrelevant,
retrieved the full text of the remaining studies, and iden-
tified relevant articles. We also reviewed the reference
lists of identified articles, existing reviews and meta-ana-
lyses and looked for studies that were not picked up in
the main search. Authors were contacted for any addi-
tional data, if required.
Inclusion/exclusion criteria
For Doppler velocimetry, only randomized trials and
quasi-randomized studies addressing the use of Doppler
ultrasound in ‘high risk’ pregnancies were considered for
inclusion in the review. Women with ‘high risk’ preg-
nancies were defined as those women with singleton or
twin pregnancy in which the maternal or fetal condition
could be expected to lead to fetal compromise, e.g. iden-
tified intrauterine growth restriction, post-term pregnan-
cies, previous pregnancy loss, women with hypertension,
diabetes or other maternal pathology (e.g. thrombophi-
lia) [13]. Only those studies have been considered for
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inclusion in the review in which Doppler ultrasound of
fetal and umbilical vessels was performed. Studies
addressing utero-placental circulation were excluded
however where umbilical artery or fetal Doppler was
combined with utero-placental Doppler, the study has
been included in this review.
For the fetal movement monitoring, we included ran-
domized controlled trials, quasi-randomized and observa-
tional studies. The included studies either compared
different methods of fetal movement monitoring vs. no
fetal movement monitoring, mixed or undefined moni-
toring. Studies addressing effectiveness of fetal movement
counting in high risk pregnancies and/or unselected
populations were considered.
Data abstraction and validity assessment
All relevant data from final studies were abstracted on a
standardized Excel spreadsheet (Additional file 2). Key
variables extracted included study design, setting, alloca-
tion concealment, blinding, loss to follow-up, details of
the intervention and comparison groups and the out-
comes. The studies were assessed and graded according
to the CHERG adaptation of the GRADE technique [12].
This method of assessment is based on strengths and
limitations of individual studies. The studies are graded
as ‘high’ ‘moderate’ ‘low’ or ‘very low’ quality based on
study design, study quality, relevance to the objectives of
the review and consistency across studies [11]. A rando-
mized or cluster randomized trial initially received a high
score which was downgraded to moderate if study design
limitations or biases were present. In addition, studies
having intent-to-treat analysis or a statistically significant
strong association received 1-2 grade increases. Any
study with a final grade of ‘very low’ was excluded from
the analysis.
Quantitative data synthesis
We generated meta-analyses where data were available
from more than one study and intervention and control
groups did not have gross clinical heterogeneity. The
primary outcome was stillbirths and/or perinatal death.
The main comparison for Doppler velocimetry studies
was Doppler ultrasound of fetal vessels versus no Dop-
pler ultrasound of fetal vessels (including comparisons
of Doppler ultrasound of fetal vessels concealed versus
Doppler ultrasound of fetal vessels revealed). For cluster
randomized trials, we used the stated cluster adjusted
relative risk and 95% confidence interval, irrespective of
the method used. We adjusted the results for cluster
design if not stated in the study. The assessment of sta-
tistical heterogeneity among trials was done by visual
inspection i.e. the overlap of the confidence intervals
among the studies, and by the Chi square (P-value) of
heterogeneity in the meta-analyses and I2 value. A low P
value (less than 0.10) or a large chi-squared statistic
relative to its degree of freedom (I2 >50 %) was consid-
ered as providing evidence of significant heterogeneity.
In situations of substantial or high heterogeneity being
present, causes were explored by sensitivity analysis.
Fixed models were used for the primary analysis. All
meta-analyses were conducted using software Review
Manager Version 5 [14].
For recommendations to the LiST model, we summar-
ized the evidence for each outcome including qualitative
assessment of ‘overall’ evidence according to GRADE
criteria and quantitative measures according to standard
guidelines of Child Health Epidemiological Review
Group (CHERG) group [11]. The qualitative evaluation
of the overall (pooled) evidence was based on the
volume and consistency of the evidence across studies,
the size of pooled relative risk and the strength of the
statistical evidence for an association between the inter-
vention and the health outcome as reflected in the
p-value [11].
Delphi process for establishing expert consensus
We did the Delphi process for generation of effect esti-
mates for detection of IUGR by a proposed package that
includes i) maternal BMI screening, ii) symphysis-fundal
height measurement and iii) targeted ultrasound. This
process involves consultation with experts in the field
and asks their opinion about the effectiveness of an
intervention [11]. The panel invited to participate were
experts in newborn health and sepsis representing six
WHO regions (South Asia, Africa, Western Europe,
Eastern Europe, North America, Australia), and includ-
ing multiple disciplines international health, obstetrics/
gynecology/midwifery etc. Thirty-one experts agreed to
participate in the Delphi process. The questionnaire was
developed by MYY and ZAB, and refined after several
rounds of pilot testing. The questionnaire was sent by
email and included the background and aims of the
Delphi and estimates of effect that were available from
the literature for different scenarios. The median
response and range were determined for each question.
Consensus was defined a priori as an interquartile range
in responses of < 30% for each question. For those esti-
mates not reaching consensus, the plan was for results
to be electronically distributed to the panel, virtual dis-
cussion allowed, and a second round of email question-
naires sent. However, consensus was achieved after one
round of questionnaires and subsequent rounds were
not considered necessary.
Results
The detection of IUGR
This section will summarize the previous evidence and
selection of interventions for detection of IUGR in the
general population.
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Some of the methods used to predict and monitor
growth of the fetus include maternal BMI screening, sym-
physis-fundal height measurement and routine ultrasound
[15]. Maternal BMI screening had been proposed as an
effective method of predicting fetal growth by a group of
experts [16]. Two Cochrane reviews on routine ultrasono-
graphic evaluation in early (before 24 weeks of gestation)
and late pregnancy (after 24 weeks) showed no effect in
reducing overall peri-natal mortality [17,18]. Early preg-
nancy ultrasound (before 24 weeks) however was benefi-
cial in detecting multiple pregnancies and reducing rates
of induction of labor for post-term pregnancies [18].
Another Cochrane review on effectiveness of symphysis-
fundal height measurement was inconclusive as only one
trial was included and no recommendations in favor or
against of the intervention were made [19].
For detection of IUGR, our approach was based on
the results of a previous review conducted by us on dif-
ferent screening interventions during pregnancy [15].
On the basis of this review and other related evidence, a
set of three interventions was proposed [15,16]. These
interventions include (a) maternal BMI screening, (b)
symphysis-fundal height measurement and (c) targeted
ultrasound. The current evidence for these interventions
is described based on our previous review and a sum-
mary of results is presented below.
Maternal anthropometry can be used to help predict
adverse perinatal outcomes including low birth weight
and preterm birth [16,20]. Appropriate detection and
management of maternal malnutrition can significantly
reduce the occurrence of IUGR and related perinatal
adverse outcomes [21]. One of the nutritional interven-
tions that have a proven effect in reducing incidence of
SGA/IUGR is balanced protein energy supplementation
[5]. A Cochrane review by Kramer et al. on protein
energy supplementation during pregnancy had shown
that balanced protein energy supplementation can
reduce occurrence of small for gestational age births by
32% [RR 0.68 (95 % CI 0.56, 0.84)] [22].
A Cochrane review by Nielson on effectiveness of sym-
physis-fundal height measurement was inconclusive as
there was only trial that included 1369 women [19].
None of the outcomes measured was statistically signifi-
cant. Even though there was no conclusive evidence from
the only randomized trial, some observational studies
report that symphysis-fundal height measurement can be
a cost effective and relatively accurate method for mea-
surement of gestational age and subsequently fetal
growth. A recent cohort study conducted in Pakistan
compared fundal height measurement with recall of last
menstrual period (LMP) to assess gestational age [23].
The effectiveness of both the interventions was compared
with ultrasound. The results showed that symphysis-
fundal height measurement was a better method of
assessing gestational age compared to recall of LMP,
however accuracy of both the methods was less than that
of ultrasound. Authors suggested use of symphysis-fundal
height measurement as a cost effective and relatively reli-
able method of gestational age assessment and fetal
growth monitoring. Another study reported that weekly
self-administered symphysis-fundal measurements can be
used to monitor fetal growth [24]. Similar results were
found in an observation study from Brazil [25] where 753
low risk women were followed with periodic symphysis-
fundal height measurement and the results were plotted
to obtain a curve. Results showed a sensitivity of about
86 % for detection of SGA infants.
Even though routine ultrasound early (< 24 weeks of
gestation) or late (> 24 weeks) in pregnancy have not
been shown to decrease perinatal mortality [17,18],
repeated ultrasound estimation of growth can be used to
detect abnormal fetal growth [10]. We propose that if
this is combined with monitoring of fetal growth by sym-
physis-fundal height measurement and coupled with
appropriate management (e.g. early delivery), it can sub-
stantially reduce perinatal mortality and stillbirth. We did
a Delphi process to get an estimate for effectiveness of
detection and management of IUGR for inclusion in the
LiST [11]. In this process we contacted experts in the
field and took their opinion on the effectiveness of IUGR
screening using the above mentioned three methods (a-c)
coupled with the appropriate management. The process
revealed an estimated reduction of 20% each in antepar-
tum and intrapartum stillbirths (Figure 1). This estimate
had been recommended for inclusion in the LiST.
Surveillance of high risk pregnancies
(1) Fetal movement monitoring
During the literature search, a total of 994 titles were
identified (Figure 2). After an initial screening of titles
Figure 1 Box plots of the Delphi results on detection and
management of IUGR compared to no identification or action for
IUGR.
Imdad et al. BMC Public Health 2011, 11(Suppl 3):S1
http://www.biomedcentral.com/1471-2458/11/S3/S1
Page 4 of 12
and abstracts, 84 were found to be appropriate and
finally 14 studies were chosen for final data extraction.
We evaluated studies on the basis of antepartum or
intrapartum stillbirth and perinatal mortality as out-
comes. Additional file 3 gives characteristics of included
studies of fetal movement monitoring. There were four
randomized controlled trials assessing fetal movement
counting [26-29]. Three of these trials were conducted
in developed countries [26,28,29] and one in a develop-
ing country [30]. Data were not pooled due to gross
clinical heterogeneity in the assessment of fetal move-
ment monitoring and the comparison group. Two of
these trials compared different fetal movement counting
methods, and measured the acceptability, the compli-
ance and other outcomes [29,30]. No intrauterine death
was reported in any of these two trials. In another trial
fetal movement counting (modified Cardiff method) was
compared with hormonal analysis. Only one stillbirth
was reported (in the fetal counting group). However the
fetal movement counting group had significantly fewer
visits to the hospital antenatally compared to the group
undergoing hormone analysis (RR 0.26, 95% CI 0.20 to
0.35). The fourth and largest trial, was a cluster rando-
mized study by Grant et al. [26] involving 68,654
Studies reviewed with potential of 
eligibility          
Fetal movement monitoring: 84 
Doppler velocimetry: 25
Included studies  
Excluded after screening of titles and abstracts 
Fetal movement monitoring: 910 
Doppler velocimetry: 883 
Exclusion of studies not meeting our 
eligibility criteria  
Fetal movement monitoring: 70 
Doppler velocimetry: 9 
Titles screened 
Fetal movement monitoring: 994 
Doppler velocimetry: 908 
Doppler velocimetry 
n=16
Fetal movement 
monitoring 
n =14
Figure 2 Synthesis of study identification in review of screening and triage of intrauterine growth restriction in general population and high risk
pregnancies.
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women comparing fetal counting (Cardiff method) ver-
sus no instruction to monitor fetal movements. There
was no significant difference in the mean antepartum
stillbirth rate per cluster in the intervention versus con-
trol group (2.90/1000 vs. 2.67/1000). The routine
antenatal care guidelines of the UK National Institute
for Health and Clinical Excellence (NICE) [31] that do
not recommend fetal movement monitoring in uncom-
plicated pregnancies were largely dictated by the find-
ings of this trial [32].
In addition, we identified four other intervention stu-
dies [33-36] and six observational studies [37-42]. A
quasi-randomized trial by Neldam showed a statistically
significant difference in antepartum stillbirth rates
among women told to monitor fetal movements com-
pared to those not being asked to monitor movements
(0/1125 vs. 8/1125) [34]. The three before-after studies
all showed a significant decline in stillbirth rates after
formal introduction of fetal movement monitoring into
clinical practice [33,35,36].
According to the observational study by De Muylder,
high-risk women whose previously normal kick charts
became abnormal had significantly higher antepartum
stillbirth (194/1000 vs. 7/1000) and perinatal mortality
(222/1000 vs. 27/1000) rates compared to women whose
kick charts remained normal till delivery [37]. Other
observational studies have mixed data regarding stillbirth
outcome. Lema showed that poor fetal monitoring results
had higher rates of stillbirths (5/27 vs. 1/83) [40], while a
recent study by Sinha [42] found no deaths in the two
groups of women with decreased and normal fetal move-
ments (0/90 vs. 0/90) similar to the result of the study by
Romero Gutierrez on perinatal mortality [41].
(2) Doppler velocimetry
Our literature search yielded 908 titles (Figure 2). Initially
25 studies were considered for inclusion in the review.
Seven of these studies were excluded because the trial
participants were described as ‘unselected population’ or
of ‘low risk’ [43-49]. Two studies were excluded due to
insufficient data [50,51]. Finally 16 studies were included
in the review [52-67].
Additional file 4 presents the characteristics of included
studies of Doppler velocimetry. All the studies were con-
ducted in high income countries except one that was
conducted in South Africa [64]. Pooled results for impact
on stillbirth showed a reduction of 35 % [RR 0.65, 95 %
CI 0.41-1.04]; however the results did not reach the con-
ventional limits of statistical significance (Figure 3).
Study or Subgroup
Almstrom 1992
Biljan 1992
Burke 1992
Giles 2003
Haley 1997
Hofmeyr 1991
Johnstone 1993
Neales 1994
Newnham 1991
Nienhuis1997
Norman 1992
Pattinson 1994
Trudinger 1987
Tyrrell 1990
Williams 2003
Total (95% CI)
Total events
Heterogeneity: Chi² = 7.87, df = 14 (P = 0.90); I² = 0%
Test for overall effect: Z = 1.80 (P = 0.07)
Events
0
1
3
2
0
2
4
6
3
1
1
0
1
3
0
27
Total
214
338
241
524
73
438
1132
236
275
74
26
108
127
250
649
4705
Events
2
2
2
3
1
2
4
9
2
3
4
5
2
1
1
43
Total
212
336
235
528
77
459
1197
231
270
76
27
104
162
250
691
4855
Weight
5.6%
4.5%
4.5%
6.7%
3.3%
4.4%
8.7%
20.4%
4.5%
6.6%
8.8%
12.5%
3.9%
2.2%
3.3%
100.0%
M-H, Fixed, 95% CI
0.20 [0.01, 4.10]
0.50 [0.05, 5.46]
1.46 [0.25, 8.67]
0.67 [0.11, 4.00]
0.35 [0.01, 8.49]
1.05 [0.15, 7.41]
1.06 [0.27, 4.22]
0.65 [0.24, 1.80]
1.47 [0.25, 8.74]
0.34 [0.04, 3.22]
0.26 [0.03, 2.17]
0.09 [0.00, 1.56]
0.64 [0.06, 6.95]
3.00 [0.31, 28.65]
0.35 [0.01, 8.70]
0.65 [0.41, 1.04]
Experimental Control Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.005 0.1 1 10 200
Favours experimental Favours control
Figure 3 Forest plots for impact of Doppler ultrasound versus no ultrasound on stillbirths.
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Pooled results from sixteen studies showed that Doppler
velocimetry of umbilical and fetal arteries in ‘high risk’
pregnancies leads to a reduction of 29 % [RR 0.71, 95 %
CI 0.52-0.98] in perinatal mortality compared to no Dop-
pler velocimetry (Figure 4). There was no heterogeneity
(I2 =0) in both the pooled estimates.
Recommendations for LiST model
Table 1 gives an overall qualitative assessment of studies
addressing fetal movement monitoring and Doppler veloci-
metry. Data were not pooled for fetal movement monitor-
ing due to gross clinical heterogeneity in the intervention
and control groups of the included studies. We have not
recommended fetal movement monitoring for inclusion in
the LiST model due to insufficient data in favor or against
the use of intervention (GRADE quality very low).
For Doppler velocimetry, there was a significant reduc-
tion of 29% in perinatal mortality and non-significant
reduction of 35% in stillbirths in high risk pregnancies.
The results across studies were consistent in both esti-
mates and there was no significant heterogeneity in the
pooled data (I2 =0). The overall grade quality for reduction
in perinatal mortality was that of ‘moderate’ level due to
inadequate methods of sequence generation and allocation
concealment in some of the included studies. Although
the direction of effect (i.e. towards reduction) was similar
for stillbirths, the overall grade quality of evidence for
reduction in stillbirths was that of ‘moderate’ level. Keep-
ing in mind the magnitude and direction of effect of these
estimates, we recommend reduction in perinatal mortality
[29 % (95 % CI 2% to 48%)] as a proxy for reduction in
stillbirths with conversion of its overall quality grade from
‘moderate’ to ‘low’ level. This was to follow the theme of
CHERG guidelines i.e. to select the most conservative esti-
mate from the available data. The effect size for perinatal
mortality (29%) was more conservative than that of still-
birth (35%). These recommendations can be interpreted as
“Surveillance of high risk pregnancies with Doppler veloci-
metry of umbilical and fetal arteries with appropriate
timely obstetric intervention leads to a reduction of 29 %
(95 % CI 2% to 48%) in stillbirths”.
Discussion
Detection and management of IUGR
Maternal BMI screening is one of the methods that have
been suggested to predict growth of fetus and related
Study or Subgroup
Almstrom 1992
Biljan 1992
Burke 1992
Giles 2003
Haley 1997
Hofmeyr 1991
Johnstone 1993
Neales 1994
Newnham 1991
Nienhuis1997
Norman 1992
Ott 1998
Pattinson 1994
Trudinger 1987
Tyrrell 1990
Williams 2003
Total (95% CI)
Total events
Heterogeneity: Chi² = 5.99, df = 15 (P = 0.98); I² = 0%
Test for overall effect: Z = 2.09 (P = 0.04)
Events
0
1
4
7
1
4
12
11
9
2
1
1
6
1
3
0
63
Total
214
338
241
524
73
438
1132
236
275
74
26
348
108
127
250
649
5053
Events
3
4
3
8
1
8
16
14
9
3
4
1
7
5
3
1
90
Total
212
336
235
528
77
459
1197
231
270
76
27
317
104
162
250
691
5172
Weight
3.9%
4.5%
3.4%
8.9%
1.1%
8.7%
17.3%
15.7%
10.1%
3.3%
4.4%
1.2%
7.9%
4.9%
3.3%
1.6%
100.0%
M-H, Fixed, 95% CI
0.14 [0.01, 2.72]
0.25 [0.03, 2.21]
1.30 [0.29, 5.75]
0.88 [0.32, 2.41]
1.05 [0.07, 16.55]
0.52 [0.16, 1.73]
0.79 [0.38, 1.67]
0.77 [0.36, 1.66]
0.98 [0.40, 2.44]
0.68 [0.12, 3.98]
0.26 [0.03, 2.17]
0.91 [0.06, 14.50]
0.83 [0.29, 2.37]
0.26 [0.03, 2.16]
1.00 [0.20, 4.91]
0.35 [0.01, 8.70]
0.71 [0.52, 0.98]
Experimental Control Risk Ratio Risk Ratio
M-H, Fixed, 95% CI
0.01 0.1 1 10 100
Favours experimental Favours control
Figure 4 Forest plots for impact of Doppler ultrasound versus no ultrasound on perinatal mortality.
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occurrence of low birth weight, and other perinatal
adverse outcomes [16,20,21,68-73]. A Cochrane review
on effectiveness of measurement of symphysis fundal
height for detecting IUGR was inconclusive due to lack
of RCTs [19]. Observational studies however suggest
that it is a cost effective and fairly accurate tool to
detect or at least suspect abnormal fetal growth [15,23].
In case of clinical suspicion and/or existing risk factors,
repeat ultrasound can assess fetal growth and a judg-
ment can be made about optimal or suboptimal growth
[15]. However, routine ultrasound for every woman irre-
spective of indication or risk factor does not help to
reduce perinatal mortality [17,18].
Keeping in mind the existing literature reviewed else-
where by us [15], we propose a model to detect and
manage IUGR with an expected reduction in stillbirths.
This model consists of three screening interventions i.e.
maternal BMI, symphysis-fundal height measurement
and targeted ultrasound coupled with management of
cases identified. As there are currently no studies evalu-
ating this combination, we consulted experts in the field
to give us their opinion on the expected benefit of these
combined interventions in reducing IUGR and still-
births. Delphi consensus (medians) determined the
effect to be 20% reduction in ante-partum stillbirth with
an inter-quartile range of 10% to 37.5% and 20% reduc-
tion in intra-partum stillbirth with an inter-quartile
range of 5% and 30% (Figure 1).
Surveillance of high risk pregnancies
Several surveillance methods have been proposed to
detect and manage high risk pregnancy during the
antenatal or intrapartum period [6]. These methods
involve assessment of fetal well-being by taking into
account measures such as fetal movement, fetal heart
rate pattern, and/or growth; and feto-placental and/or
uteroplacental circulatory dynamics [15].
There are no clearly identified criteria to distinguish
between a ‘high’ or ‘low’ risk pregnancy; however, preg-
nancies in which the maternal and/or fetal condition pose
a threat to life of the mother or fetus are considered as
‘high risk’ [13]. Maternal conditions most commonly asso-
ciated with adverse perinatal outcomes include conditions
such as diabetes (chronic and gestational), hypertensive
disorders (chronic hypertension and pre-eclampsia) and
cardiac, renal, autoimmune and thrombophiliac disorders
[74-76]. Fetal conditions associated with ‘high risk’ preg-
nancy include fetal growth restriction, and placental insuf-
ficiency [77-79].
Table 1 Qualitative assessment of overall evidence for Doppler velocimetry and fetal movement monitoring according
to CHERG rules
Quality Assessment Summary of findings
Generalizability Number of events Pooled Effect
No. of
studies
Design Limitations Consistency Generalizability
to Population
of Interest
Generalizability to
intervention of
Interest
Intervention control RR ( 95 % CI)
Effect of surveillance of high risk pregnancies with Doppler velocimetry: Outcome perinatal mortality: Grade quality of evidence
‘Moderate’
16 RCT Methods of sequence
generation and allocation
concealment were not
adequate in most of the
studies
No
heterogeneity
(I2=0%)
All the studies
from developed
countries except
one which is
from South
Africa
Doppler
velocimetry of
umbilical and fetal
arteries for
surveillance of high
risk pregnancy
63 90 0.71 (0.52-0.98)
Effect of surveillance of high risk pregnancies with Doppler velocimetry: Outcome stillbirth: Grade quality of evidence ‘Low’
15 RCT Methods of sequence
generation and allocation
concealment were not
adequate in most of the
studies
No
heterogeneity
(I2=0%)
All the studies
from developed
countries except
one which is
from South
Africa
Doppler
velocimetry of
umbilical and fetal
arteries for
surveillance of high
risk pregnancy
27 43 0.65 (0.41-1.04)
Effect of fetal movement monitoring on stillbirths: Grade quality of evidence “very low”
14 RCT, quasi
experimental
and
observational
studies
Most of the evidence
from observation studies.
Of the four RCTs, only
one compared fetal
movement monitoring
versus no fetal
movement monitoring.
This RCT showed no
effect of fetal movement
monitoring on stillbirths
Data not
pooled due to
gross clinical
heterogeneity
Most of the
studies from
developed
countries
No consensus on
single counting
method. Cardif
method (Count to
ten) was the most
widely used
method
Data not pooled
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Doppler velocimetry is considered as one of the most
objective methods to assess fetal wellbeing in cases of
intrauterine growth restriction (IUGR) [13,15]. It pro-
vides information on fetal and placental cardiovascular
function on the basis of the blood flow dynamics mea-
sured in uterine, umbilical and fetal arteries [80].
A Cochrane review by Alfirevic et al. comprising of 16
studies and involving 10, 225 babies had shown that
fetal and umbilical artery Doppler ultrasound in high
risk pregnancies can decrease the perinatal mortality by
29 % (RR 0.71, 95 % CI 0.52-0.98), when obstetric ser-
vices were in place to ensure safe and timely delivery of
the baby when needed. Uterine artery Doppler waveform
analysis on the other hand, may identify compromised
fetuses at risk of stillbirth, especially in cases of placen-
tal underperfusion associated with preeclampsia and/or
growth restriction; however published literature does
not show its effectiveness of subsequent intervention to
prevent stillbirths [15]. We had therefore focused on
effectiveness of Doppler velocimetry of fetal and umbili-
cal arteries for the fetal wellbeing in case of surveillance
of IUGR.
According to CHERG rules, we recommended a
reduction of 29 % (95 % CI 2% to 48%) in stillbirths for
high risk pregnancies if these are identified, followed by
Doppler velocimetry of fetal and umbilical arteries and
managed with the appropriate intervention (e.g. early
delivery). This estimate was the most conservative of the
estimates for reduction in perinatal mortality and still-
births. The results for reduction in stillbirths did not
reach statistical significance. The overall grade quality
for the pooled estimate for still births was ‘low’. This
was because the quality of methods of sequence genera-
tion and allocation concealment was inadequate in some
of the included studies. We therefore propose to take
reduction in perinatal mortality as a proxy for reduction
in stillbirths. Our results are in accordance with the pre-
vious meta-analysis done on this topic [13]. It is impor-
tant to take into account that Doppler ultrasound is
used as a diagnostic assessment method and the clinical
outcomes depend on availability of and implementation
of timely interventions such as early delivery e.g. via cae-
sarean sections.
Fetal movement counting is a simple, inexpensive and
the oldest way to monitor the condition of the baby
during pregnancy and is considered to be an indirect
measure of central nervous system integrity [42,81]. Fetal
movements in the womb can be felt by the mothers from
around 16 to 20 weeks of gestation [82]. A reduction in
fetal movements is associated with decreased oxygena-
tion, which may lead to fetal growth compromise or still-
birth [83]. A review based on twenty-four Western
studies demonstrated that reduced fetal movements were
associated with adverse pregnancy outcomes, both in
high and low risk pregnancies [84]. Therefore, decreased
fetal movements may be a sign of fetal compromise or
impending fetal demise. Other causes of reduced fetal
movements include decreased amniotic fluid, drugs,
sedatives and sleep state in the fetus [85]. A Cochrane
review by Mangesi and Hofmyer, comprising four rando-
mized controlled trials and including 71,370 women,
found no convincing evidence to recommend in favor or
against routine fetal movement monitoring in unselected
or high risk pregnancies [86].
In developing countries, where advanced facilities are
not available, fetal movement monitoring may be feasi-
ble, but its use is currently not supported by scientific
evidence. We have graded the current evidence as ‘very
low’ which means that there is not sufficient evidence to
include this intervention in the LiST model. We how-
ever consider it important to study this simple and old-
est intervention in more detail to assess if it is useful to
detect and follow high risk pregnancies especially in
developing countries.
Conclusions
In conclusion, Detection and management of IUGR
using maternal BMI screening, symphysis-fundal height
measurement and targeted ultrasound could be effective
method of reducing IUGR related stillbirths. There are
currently no studies available to assess the effect of
these methods. Based on the opinion of experts in the
field, this combination coupled with effective manage-
ment could reduce IUGR related antepartum and intra-
partum stillbirth by 20% each.
Doppler velocimetry of umbilical and fetal arteries for
surveillance of identified high risk pregnancies leads to a
reduction of 29% (95 % CI 2% to 48 %) in perinatal
mortality. The direction of effect on the incidence of
stillbirths was also similar but not statistically significant
[RR 0.65, 95 % CI 0.41-1.04]. We recommend an esti-
mate reduction of 29 % (95 % CI 2% to 48%) in still-
births for inclusion in the Lives Saved Tool on the basis
of rules developed by Child Health Epidemiology Refer-
ence Group. There is insufficient evidence to recom-
mend in favor or against of fetal movement counting.
More research is needed to study this method especially
in developing countries.
Key messages
Doppler Velocimetry of umbilical and fetal arteries in
women with high risk pregnancies leads to a reduction
of 29 % (95 % CI 2% to 48 %) in perinatal mortality.
Pooled results for impact of Doppler Velocimetry on
stillbirth show a statistically non-significant reduction of
35 % [RR 0.65, 95 % CI 0.41-1.04].
According to Child Health Epidemiology Group, we
have recommended reduction in perinatal mortality by
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[29 % (95 % CI 2% to 48 %)] as a proxy for reduction in
stillbirths in high risk pregnancies. It is important to
take into account that Doppler ultrasound is a screening
test and cannot influence clinically important outcomes
itself. The clinical outcomes depend on availability of
appropriate facilities to manage the patient.
Detection and management of IUGR using maternal
BMI screening, symphysis-fundal height measurement
and targeted ultrasound followed by appropriate man-
agement can be an effective method of reducing IUGR
related stillbirths. Based on the opinion of experts in the
field, this combination could reduce antepartum and
intrapartum stillbirth by 20%.
Additional material
Additional File 1: Word document containing the search terms used
in the two searches.
Additional File 2: An excel sheet that show the data extraction
sheet for studies evaluating Doppler velocimetry and fetal
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